Acadian Asset Management
AGIO icon

Acadian Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Acadian Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Buy
+5,859
New +$166K ﹤0.01% 1594
2025
Q2 		– Sell
-4,544
Closed -$133K – 1645
2025
Q1 		$133K Buy
+4,544
New +$151K ﹤0.01% 1310
2024
Q3 		– Sell
-864
Closed -$37K – 2060
2024
Q2 		$37K Buy
+864
New +$31.2K ﹤0.01% 1627
2021
Q3 		– Sell
-1,686
Closed -$93K – 1696
2021
Q2 		$93K Buy
+1,686
New +$94.3K ﹤0.01% 1644
2020
Q3 		– Sell
-1,233
Closed -$66K – 2151
2020
Q2 		$66K Buy
+1,233
New +$57.1K ﹤0.01% 1836
2017
Q1 		– Sell
-2,526
Closed -$105K – 1544
2016
Q4 		$105K Buy
+2,526
New +$133K ﹤0.01% 1096

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return